![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 12, 8854-8862, March 24, 2000
§
From the Department of Biological Chemistry and the
Ras plays an important role in a variety of
cellular functions, including growth, differentiation, and oncogenic
transformation. For instance, Ras participates in the activation of
Raf, which phosphorylates and activates mitogen-activated protein
kinase kinase (MEK), which then phosphorylates and activates
extracellular signal-regulated kinase (ERK), a mitogen-activated
protein (MAP) kinase. Activation of MAP kinase appears to be essential
for propagating a wide variety of extracellular signals from the plasma
membrane to the nucleus. N17Ras, a GDP-bound dominant negative mutant, is used widely as an interfering mutant to assess Ras function in
vivo. Surprisingly, we observed that expression of N17Ras
inhibited the activity and phosphorylation of Elk-1, a physiological
substrate of MAP kinases, in response to phorbol myristate acetate. The activity and phosphorylation of the MAP kinase hemagglutinin epitope (HA)-ERK1 were not affected by N17Ras in response to the same stimulus.
Additionally, expression of N17Ras, but not L61S186Ras, a GTP-bound
interfering mutant, inhibited MEK-induced Elk-1 phosphorylation, suggesting that inhibition of Elk-1 may be unique to GDP-bound Ras
mutants. Finally, we observed that V12Ras-induced focus formation in
NIH3T3 cells is inhibited by coexpression of GDP-bound Ras mutants,
such as N17, A15, and N17N69. Therefore, N17Ras and V12 Ras may be
codominant with respect to Elk-1 activation and cellular transformation. These results indicate that N17Ras appears to have at
least two distinguishable functions: interference with endogenous Ras
activation and inhibition of Elk-1 and transfomation. Furthermore, our
data imply the possibility that GDP-bound Ras, like N17Ras, may have a
direct role in signal transduction.
Institute of Gerontology, University of Michigan Medical
School, Ann Arbor, Michigan 48109
This article has been cited by other articles:
![]() |
P. A. Kelly and Z. Rahmani DYRK1A Enhances the Mitogen-activated Protein Kinase Cascade in PC12 Cells by Forming a Complex with Ras, B-Raf, and MEK1 Mol. Biol. Cell, August 1, 2005; 16(8): 3562 - 3573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singh, A. P. Sowjanya, and G. Ramakrishna The wild-type Ras: road ahead FASEB J, February 1, 2005; 19(2): 161 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dasgupta, W. Li, A. Perry, and D. H. Gutmann Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes Cancer Res., January 1, 2005; 65(1): 236 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Stoll, V Calleja, G Vassaux, J Downward, and N R Lemoine Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer Gut, January 1, 2005; 54(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, K. Inoki, and K.-L. Guan Biochemical and Functional Characterizations of Small GTPase Rheb and TSC2 GAP Activity Mol. Cell. Biol., September 15, 2004; 24(18): 7965 - 7975. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Chiu, J. Silletti, V. Dinsell, H. Wiener, K. Loukeris, G. Ou, M. R. Philips, and M. H. Pillinger Carboxyl Methylation of Ras Regulates Membrane Targeting and Effector Engagement J. Biol. Chem., February 20, 2004; 279(8): 7346 - 7352. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, J. Li, D. L. Johnson, and J.-h. Ou Regulation of Hepatitis B Virus Replication by the Ras-Mitogen-Activated Protein Kinase Signaling Pathway J. Virol., July 15, 2003; 77(14): 7707 - 7712. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Villalonga, C. Lopez-Alcala, A. Chiloeches, J. Gil, R. Marais, O. Bachs, and N. Agell Calmodulin Prevents Activation of Ras by PKC in 3T3 Fibroblasts J. Biol. Chem., September 27, 2002; 277(40): 37929 - 37935. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Diaz, D. Ahn, L. Lopez-Barcons, M. Malumbres, I. Perez de Castro, J. Lue, N. Ferrer-Miralles, R. Mangues, J. Tsong, R. Garcia, et al. The N-ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene Cancer Res., August 1, 2002; 62(15): 4514 - 4518. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, I. Jaspers, W. Zhang, L. M. Graves, and J. M. Samet Role of Ras in metal-induced EGF receptor signaling and NF-kappa B activation in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1040 - L1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zugasti, W. Rul, P. Roux, C. Peyssonnaux, A. Eychene, T. F. Franke, P. Fort, and U. Hibner Raf-MEK-Erk Cascade in Anoikis Is Controlled by Rac1 and Cdc42 via Akt Mol. Cell. Biol., October 1, 2001; 21(19): 6706 - 6717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Vikis, W. Li, Z. He, and K.-L. Guan The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner PNAS, October 12, 2000; (2000) 220421797. [Abstract] [Full Text] |
||||
![]() |
H. G. Vikis, W. Li, Z. He, and K.-L. Guan The semaphorin receptor plexin-B1 specifically interacts with active Rac in a ligand-dependent manner PNAS, November 7, 2000; 97(23): 12457 - 12462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |